Kampar

Researchers are evaluating the effects of a beverage containing chamomile and L-theanine on menstrual symptoms, pain intensity, mood, and sleep quality in young adult females with primary dysmenorrhea. This study focuses on females aged 18 to 30 years who experience primary dysmenorrhea with a pain score of 4 cm or higher on the visual analogue scale VAS for the last three consecutive menstrual cycles. The study excludes women who are pregnant, breastfeeding, or have secondary dysmenorrhea or other relevant medical conditions. Participants are randomly assigned to one of two groups. The intervention group will consume a beverage containing 480 mg of chamomile extract and 200 mg of L-theanine, while the control group will drink a chamomile-flavored beverage without L-theanine. Both groups receive their respective beverages throughout the study period, which lasts for two months. During the study, participants will be monitored for changes in pain intensity, menstrual symptoms, mood, and sleep quality. Researchers will also assess hemoglobin levels at the end of the two-month period. The study uses double masking to ensure unbiased results, and all participants will be regularly evaluated to track their symptoms and overall well-being during this time.